Myriad Genetics Inc (NAS:MYGN)
$ 25.29 0.7 (2.84%) Market Cap: 2.29 Bil Enterprise Value: 2.33 Bil PE Ratio: 0 PB Ratio: 3.01 GF Score: 76/100

Q2 2020 Myriad Genetics Inc Earnings Call Transcript

Feb 06, 2020 / 09:30PM GMT
Release Date Price: $29.29 (-0.81%)
Operator

Greetings, and welcome to the Myriad Genetics Second Quarter 2020 Financial Earnings call. (Operator Instructions) As a reminder, this conference is being recorded today, Thursday, February 6, 2020. I would now like to turn the conference over to Scott Gleason, VP, Investor Relations. Please go ahead.

Scott Gleason
Myriad Genetics, Inc. - VP of IR

Thanks, Dave. Good afternoon, and welcome to the Myriad Genetics Fiscal Second Quarter 2020 Earnings Call. During the call, we will review the financial results we released today, after which we will host a question-and-answer session. If you've not had a chance to review our quarterly earnings release, it can be found on our website at myriad.com.

Presenting for Myriad today will be Bryan Riggsbee, Chief Executive Officer. This call can be heard live via [email protected], and a recording will be archived in the Investors section of our website. In addition, there's a slide presentation pertaining in today's earnings call on the Investors section of our website and which will be filed following the call on

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot